B-Rapidly Accelerated Fibrosarcoma (BRAF) mutations, most commonly V600E and V600K, are key drivers of melanoma, occurring in approximately 60% of cutaneous melanoma worldwide [34,35]. This evidence concerns the gene BRAF and cutaneous melanoma.